Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Frontiers in Human Neuroscience|October 30, 2018
Environmental-friendly Eco-labeling Matters: Evidences From an ERPs StudyJia Jin, Xiaodong Dou, Liang Meng, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2017
Discovery of new GSK-3β inhibitors through structure-based virtual screeningXiaodong Dou, Lan Jiang, Yanxing Wang, et al.Acta Pharmaceutica Sinica. B|March 15, 2024
Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editingTongyu Huo, Xinyi Zhao, Zengrui Cheng, et al.European Journal of Medicinal Chemistry|March 30, 2019
Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemiaYanxing Wang, Xiaodong Dou, Lan Jiang, et al.Organic & Biomolecular Chemistry|April 3, 2020
Engineering a bacterial sialyltransferase for di-sialylation of a therapeutic antibodyMingqun Wang, Yue Wang, Kaimeng Liu, et al.Journal of Medicinal Chemistry|February 19, 2026
Discovery of <i>N</i>-Ethyl Sulfonamide Derivatives as Potent Intestinal-Restricted Farnesoid X Receptor Antagonists for the Treatment of Metabolic DisordersLingyu Su, Tongyu Huo, Xinyi Zhao, et al.European Journal of Medicinal Chemistry|July 1, 2020
Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitorsXiaodong Dou, Huixia Huang, Lan Jiang, et al.Science (New York, N.Y.)|December 7, 2019
Nitromethane as a nitrogen donor in Schmidt-type formation of amides and nitrilesJianzhong Liu, Cheng Zhang, Ziyao Zhang, et al.European Journal of Medicinal Chemistry|May 6, 2026
Identification of a novel HNF4α agonist regulating abnormal metabolismTzumei Wang, Chaochun Wei, Jingwen Li, et al.Journal of Medicinal Chemistry|July 4, 2019
Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative DiseasesXiaodong Dou, Huixia Huang, Yibo Li, et al.Pageof 2